agree, i am sure they are will take advantage of the weaker market conditions to make a lower offer, if still they like what they have found in the books.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
